ID: ALA5265919

Max Phase: Preclinical

Molecular Formula: C15H13N3

Molecular Weight: 235.29

Associated Items:

Representations

Canonical SMILES:  Cn1cnc(-c2ccccc2)c1-c1ccncc1

Standard InChI:  InChI=1S/C15H13N3/c1-18-11-17-14(12-5-3-2-4-6-12)15(18)13-7-9-16-10-8-13/h2-11H,1H3

Standard InChI Key:  NSJCXUONRHOYTD-UHFFFAOYSA-N

Associated Targets(Human)

NSD3 Tchem Histone-lysine N-methyltransferase NSD3 (55 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 235.29Molecular Weight (Monoisotopic): 235.1109AlogP: 3.15#Rotatable Bonds: 2
Polar Surface Area: 30.71Molecular Species: NEUTRALHBA: 3HBD: 0
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 5.33CX LogP: 2.46CX LogD: 2.46
Aromatic Rings: 3Heavy Atoms: 18QED Weighted: 0.68Np Likeness Score: -0.94

References

1. Vaidergorn MM, da Silva Emery F, Ganesan A..  (2021)  From Hit Seeking to Magic Bullets: The Successful Union of Epigenetic and Fragment Based Drug Discovery (EPIDD + FBDD).,  64  (19.0): [PMID:34591474] [10.1021/acs.jmedchem.1c00787]

Source